Thermo Fisher breaks through a fresh 52-week high, shares extend the S&P 500 run

Thermo Fisher pushed to a new 52-week high on the NYSE this week, with analysts keeping a broadly positive stance on the life sciences tools group.

By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 14:18.

Thermo Fisher Scientific (US8835561023) marked a new 52-week high on the NYSE this week as the shares reached 493 dollars on June 24. The stock is a constituent of the S&P 500 and continues to attract positive analyst coverage according to recent data.

What the latest high shows

MarketBeat and other quote services report that Thermo Fisher Scientific closed at 492.38 dollars on June 24, up around 4.9 percent on the day and within a trading range between 473.50 and 493 dollars. This move pushed the shares to a fresh 52-week high, underscoring renewed investor interest in life sciences tools and services.

TradingKey data point to a market capitalization of roughly 182.9 billion dollars for the company and a trailing price-to-earnings ratio of about 27 as of the latest close. The same source notes that analysts collectively rate the stock Buy with an average price target in the lower 600-dollar range, indicating a supportive consensus backdrop.

Analyst sentiment and sector context

Analyst coverage has remained constructive in recent weeks. According to a summary on Yahoo Finance referencing TheFly, Wolfe Research analyst Mike Polark initiated coverage of Thermo Fisher Scientific on June 1 with an Outperform rating and a price target of 535 dollars. This sits below some broader consensus figures reported by aggregation services, but still implies upside from the current trading region.

Thermo Fisher competes with other large life sciences and diagnostics groups such as Danaher and Agilent Technologies, which also operate in instruments, consumables and services for laboratories. The sector has seen renewed attention as investors look for stable cash flows and exposure to biopharma and research spending, supporting valuations for diversified tools providers.

The business behind the stock

Thermo Fisher Scientific generates revenue across four broad segments: life sciences solutions, analytical instruments, specialty diagnostics and laboratory products and biopharma services. A representative offering is its portfolio of Applied Biosystems genetic analysis instruments and reagents, which laboratories use worldwide for PCR and sequencing applications.

Where the shares trade today

Thermo Fisher Scientific shares (US8835561023) trade on the NYSE under the ticker TMO. As of 2026-06-24, 16:00 Eastern, the last regular-session close stood at 492.24 dollars according to TradingKey data, with the same level quoted as the latest price on June 25.

Key data on the Thermo Fisher shares

• Company: Thermo Fisher Scientific Inc.
• ISIN: US8835561023
• WKN: 857209
• Ticker: TMO
• Trading venue: NYSE
• Price (as of 2026-06-24, 16:00): 492.24 USD
• Market cap: 182.93 billion USD (as of 2026-06-24)
• Sector / industry: Life Sciences Tools & Services
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell any security, or a solicitation of any offer. Figures and facts are based on sources believed to be reliable at the time of publication but may change without notice.